| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.18▲ | 1.18▲ | 1.19▲ | 1.18▲ | 1.27▼ |
| MA10 | 1.18▲ | 1.19▲ | 1.20▼ | 1.20▼ | 1.26▼ |
| MA20 | 1.18▲ | 1.21▼ | 1.20▼ | 1.29▼ | 1.49▼ |
| MA50 | 1.19▼ | 1.19▲ | 1.20▼ | 1.29▼ | 2.02▼ |
| MA100 | 1.21▼ | 1.21▼ | 1.26▼ | 1.51▼ | 2.68▼ |
| MA200 | 1.20▼ | 1.28▼ | 1.26▼ | 1.94▼ | 6.58▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.005▼ | -0.002▼ | -0.011▼ | 0.012▲ |
| RSI | 55.115▲ | 47.188▼ | 47.949▼ | 43.803▼ | 39.997▼ |
| STOCH | 41.667 | 8.923▼ | 14.441▼ | 23.446 | 42.937 |
| WILL %R | 0.000▲ | -72.727 | -86.957▼ | -74.076 | -64.277 |
| CCI | 212.121▲ | -71.440 | -69.961 | -68.994 | -62.481 |
| MA | $ALLO Price Crossed Above MA(7) | Set Alert |
|
Thursday, June 12, 2025 08:30 AM
A month has gone by since the last earnings report for Allogene Therapeutics (ALLO). Shares have added about 52.2% in that time frame, outperforming the S&P 500. Will the recent positive trend ...
|
|
Monday, June 02, 2025 12:41 PM
On June 1, Allogene Therapeutics Inc. (NASDAQ:ALLO) presented updated data from the Phase 1 TRAVERSE study of ALLO-316 in advanced or metastatic renal cell carcinoma/RCC during an oral ...
|
|
Sunday, June 01, 2025 07:50 AM
“ALLO-316 is showing clear evidence of targeted antitumor activity in patients who had failed most or all approved therapies for advanced or metastatic renal cell carcinoma,” said Zachary ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 03/07/25 | 1.20 | 1.21 | 1.17 | 1.19 | 1,384,912 |
| 02/07/25 | 1.19 | 1.29 | 1.18 | 1.20 | 4,810,250 |
| 01/07/25 | 1.13 | 1.23 | 1.11 | 1.18 | 2,211,580 |
| 30/06/25 | 1.18 | 1.19 | 1.12 | 1.13 | 2,137,898 |
| 27/06/25 | 1.20 | 1.23 | 1.17 | 1.18 | 5,178,774 |
| 26/06/25 | 1.23 | 1.245 | 1.16 | 1.20 | 3,129,087 |
| 25/06/25 | 1.26 | 1.275 | 1.21 | 1.24 | 1,460,855 |
| 24/06/25 | 1.22 | 1.29 | 1.20 | 1.25 | 3,013,406 |
| 23/06/25 | 1.20 | 1.2595 | 1.18 | 1.22 | 1,610,080 |
| 20/06/25 | 1.31 | 1.3292 | 1.2101 | 1.23 | 3,630,549 |
|
|
||||
|
|
||||
|
|